35 Result: Box
FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis
October 30th, 2026
Groundbreaking therapy provides additional treatment option that fights the disease at its source, not only its symptoms Silver Spring, MD / CRWE PRESS RELEASE / October 30, 2026 - The U.S. Food and Drug Administration today granted accelera. Read more
FTC and State Partners Sue Dollar General for Charging Consumers More than Advertised for Many Products
October 26th, 2026
WASHINGTON, D.C. / CRWE PRESS RELEASE / October 26, 2026 - The Federal Trade Commission, joined by 20 states, sued Dollar General Corporation for engaging in long-running deceptive pricing practices by routinely charging customers more at the r. Read more
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
October 21st, 2026
New treatment may allow some patients to maintain viral control after stopping all hepatitis B therapy Silver Spring, MD / CRWE PRESS RELEASE / October 20, 2026 - The U.S. Food and Drug Administration today approved Hibsago (bepirovirsen) inj. Read more
FTC Secures Fair Pricing Protections by Taking Action Against Major Wholesale T-Shirt Distributors
October 08th, 2026
FTC action signals continued Robinson-Patman Act enforcement to protect consumers, small businesses WASHINGTON, D.C. / CRWE PRESS RELEASE / October 8, 2026 - The Federal Trade Commission secured changes to a partnership agreement between T-sh. Read more
FTC Takes Action Against Payment Processor Humboldt Merchant Services for Knowingly Facilitating Payment Processing for Sham Merchants
September 08th, 2026
Under proposed order, defendant will be required to pay $12 million, stop payment processing for certain categories of merchants WASHINGTON, D.C. / CRWE PRESS RELEASE / September 8, 2026 - Payment processing company Humboldt Merchant Services. Read more
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
September 04th, 2026
Silver Spring, MD / CRWE PRESS RELEASE / September 04, 2026 - The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innov. Read more
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
August 27th, 2026
Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease. Silver Spring, MD / CRWE PRESS RELEASE / August 27, 2026 - The U.S. Food and Drug Administration . Read more
FAA Opens New Asheville Air Traffic Control Tower to Support Record Growth in Western North Carolina
August 07th, 2026
ASHEVILLE, N.C. / CRWE PRESS RELEASE / August 7, 2026 - The FAA today announced the opening of Asheville Regional Airport’s (AVL) new 121-foot air traffic control tower, which replaces the old facility built in 1961. The new facility provi. Read more
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
June 15th, 2026
First disease modifying therapy approval for new onset stage 3 diabetes represents a significant milestone for the pediatric type 1 diabetes community Silver Spring, MD / CRWE PRESS RELEASE / June 15, 2026 - On June 12, 2026, the U.S. F. Read more
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
May 22nd, 2026
Silver Spring, MD / CRWE PRESS RELEASE / May 22, 2026 - Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advance. Read more
FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia
April 30th, 2026
Silver Spring, MD / CRWE PRESS RELEASE / April 30, 2026 - The U.S. Food and Drug Administration today approved an expanded use for Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets to treat agitat. Read more
FDA Approves First New Molecular Entity Under National Priority Voucher Program
April 01st, 2026
Action marks the fastest approval of an NME since 2002 Silver Spring, MD / CRWE PRESS RELEASE / April 01, 2026 - The U.S. Food and Drug Administration today approved Foundayo (orforglipron), marking the fifth approval under the Commissioner's Nati. Read more
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
March 25th, 2026
Silver Spring, MD / CRWE PRESS RELEASE / March 25, 2026 - The U.S. Food and Drug Administration approved Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II). &ldq. Read more
Bondezz™ Appoints Brian Colando as Vice President of Sales to Lead Wholesale Expansion
October 24th, 2025
Las Vegas, NV / CRWE PRESS RELEASE / October 24, 2025 — FOR IMMEDIATE RELEASE — Bondezz™, today announced the appointment of Brian Colando as Vice President of Sales. In this role, Brian Colando will oversee the development of. Read more
Box Posts Upbeat Results, Outlook Disappoints; Insider Confidence Boosts Beyond Air
August 29th, 2023
Box, Inc. (NYSE: BOX), a cloud content management and file-sharing company, announced second-quarter fiscal 2024 earnings of $0.36 per share, surpassing the consensus EPS estimate of $0.35. The company's quarterly sales reached $261.43 million, sligh. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Global Scam Networks and the Corporate Infrastructure That Enables Them
November 06th, 2026FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
November 05th, 2026New Details Emerge in Amazon Ads Auction-Rigging Case
November 05th, 2026November 02nd, 2026
Member Login